Azienda Sociosanitaria Ligure 2
- Address
- Piazza Sandro Pertini 10, 17100 Savona, Italy
Cardiovascular Diseases
At Azienda Sociosanitaria Ligure 2, research in cardiovascular diseases focuses on major conditions such as hypertension, type 2 diabetes, and broader heart disease. These trials are designed to assess new treatment strategies that may reduce serious outcomes like heart-related hospitalisation and death.
- Evaluating treatment approaches for cardiovascular disease and related risk conditions
- Studying hypertension and type 2 diabetes in patients with established heart disease
- Testing therapies aimed at preventing worsening heart and kidney complications
This area reflects a strong interest in improving long-term cardiometabolic care and protecting patients from severe cardiovascular events.
Neoplasms
Clinical research in neoplasms at this site includes studies in head and neck cancer, with a focus on improving outcomes for people with locally advanced disease. The trials are exploring whether new therapies can strengthen cancer control after standard treatment.
- Investigating head and neck squamous cell carcinoma
- Assessing new options to improve cancer treatment effectiveness
- Supporting research on therapy sequencing after standard care
This work highlights the site’s role in advancing oncology research and refining treatment approaches for difficult-to-treat cancers.
Nervous System Diseases
Trials in nervous system diseases are centered on migraine, with the aim of improving relief for acute attacks and making treatment more reliable for patients. The research is focused on evaluating whether a new option can offer effective symptom control compared with placebo.
- Studying migraine treatment for acute attacks
- Examining how well a new therapy works for pain and symptom relief
- Looking at consistency of benefit in migraine care
This therapeutic area supports better neurology care by exploring more effective ways to manage a common and often disabling condition.
Reproductive and Urinary Physiological Phenomena
Research linked to reproductive and urinary physiological phenomena is focused on chronic kidney disease, often in combination with heart failure and cardiovascular risk. These studies aim to determine whether new treatment combinations can slow disease progression and improve patient outcomes.
- Investigating chronic kidney disease and its connection to heart health
- Evaluating strategies to prevent worsening kidney function
- Testing treatments intended to lower serious kidney and cardiac complications
This work shows a clear emphasis on kidney protection and integrated care for patients with overlapping renal and cardiovascular conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Boehringer Ingelheim Espana S.A.1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Azienda Sociosanitaria Ligure 2
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack | Janssen Cilag International | Phase III | Not Recruiting | Aug 2023 | — |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2023-08-04 | 2023-08-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.